Encompass Health Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 6 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Encompass Health stock.
View analyst ratings for Encompass Health or view top-rated stocks.

Wall Street analysts have given Encompass Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Encompass Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Encompass Health is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for Encompass Health.

Encompass Health Co. (NYSE:EHC) posted its quarterly earnings data on Monday, July, 26th. The company reported $1.17 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.98 by $0.19. The business had revenue of $1.29 billion for the quarter, compared to analysts' expectations of $1.28 billion. Encompass Health had a trailing twelve-month return on equity of 19.49% and a net margin of 7.83%. The firm's revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.34 earnings per share.
View Encompass Health's earnings history.

Encompass Health's stock was trading at $63.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, EHC shares have increased by 18.9% and is now trading at $75.92.
View which stocks have been most impacted by COVID-19.

Encompass Health announced a quarterly dividend on Tuesday, July 20th. Stockholders of record on Friday, October 1st will be paid a dividend of $0.28 per share on Friday, October 15th. This represents a $1.12 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date of this dividend is Thursday, September 30th.
View Encompass Health's dividend history.

Encompass Health pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.47%. The dividend payout ratio of Encompass Health is 38.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 24.14% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.
View Encompass Health's dividend history.

Encompass Health issued an update on its FY 2021 earnings guidance on Tuesday, August, 3rd. The company provided earnings per share (EPS) guidance of $4.320-$4.470 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.110. The company issued revenue guidance of $5.10 billion-$5.25 billion, compared to the consensus revenue estimate of $5.14 billion.

7 analysts have issued 12 month price targets for Encompass Health's stock. Their forecasts range from $94.00 to $110.00. On average, they expect Encompass Health's share price to reach $102.14 in the next twelve months. This suggests a possible upside of 34.5% from the stock's current price.
View analysts' price targets for Encompass Health or view top-rated stocks among Wall Street analysts.

231 employees have rated Encompass Health CEO Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among Encompass Health's employees.

Some companies that are related to Encompass Health include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Tenet Healthcare (THC), Acadia Healthcare (ACHC), Petco Health and Wellness (WOOF), Select Medical (SEM), The Ensign Group (ENSG), U.S. Physical Therapy (USPH), Community Health Systems (CYH), Brookdale Senior Living (BKD), National HealthCare (NHC), Five Star Senior Living (FVE) and Capital Senior Living (CSU).
View all of EHC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include salesforce.com (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Encompass Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.74%), Vanguard Group Inc. (9.36%), William Blair Investment Management LLC (3.98%), State Street Corp (2.60%), American Century Companies Inc. (1.78%) and Victory Capital Management Inc. (1.70%). Company insiders that own Encompass Health stock include Andrew L Price, Andrew L Price, Donald L Correll, Donald L Correll, Elissa Joy Charbonneau, Elissa Joy Charbonneau, Mark J Tarr and Mark J Tarr.
View institutional ownership trends for Encompass Health.

EHC stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, William Blair Investment Management LLC, American Century Companies Inc., Principal Financial Group Inc., Victory Capital Management Inc., BlackRock Inc., Epoch Investment Partners Inc., and Envestnet Asset Management Inc.. Company insiders that have sold Encompass Health company stock in the last year include Andrew L Price, and Elissa Joy Charbonneau.
View insider buying and selling activity for Encompass Health or view top insider-selling stocks.

EHC stock was purchased by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Point72 Asset Management L.P., Man Group plc, Great Lakes Advisors LLC, State Street Corp, Los Angeles Capital Management LLC, Magnetar Financial LLC, and Qube Research & Technologies Ltd.
View insider buying and selling activity for Encompass Health or or view top insider-buying stocks.

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EHC stock can currently be purchased for approximately $75.92.

Encompass Health has a market capitalization of $7.55 billion and generates $4.64 billion in revenue each year. The company earns $284.20 million in net income (profit) each year or $2.89 on an earnings per share basis.

Encompass Health employs 43,000 workers across the globe.

Encompass Health was founded in 1984.

The official website for Encompass Health is www.healthsouth.com.

Encompass Health is headquartered at 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States.

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at (205) 967-7116 or via email at [email protected].